Ipca Laboratories

L24239MH1949PLC007837 · ISIN — · 4 filings, FY 2022-23 to FY 2025-26 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

py_column_contradicts_prior_filing. AmountOfRecycled for period ending 2025-03-31 reported as [0.0, 1339.0] in different filings. Restated or mis-tagged.

py_column_contradicts_prior_filing. AmountOfSafelyDisposed for period ending 2025-03-31 reported as [0.0, 11507.0] in different filings. Restated or mis-tagged.

CategoryFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Plastics including packaging not filednot filed01,371
E-waste not filednot filed00
Hazardous waste not filednot filed014,112
Other waste not filednot filednot filednot filed
Total reclaimed 00015,483

Recycled or reused input material

Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.

Input material, as filedFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Solvent recovery not filednot filednot filed70.0%

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
21002 Manufacture of Pharmaceuticals 100.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Standalone 2021-09-30 5,925.81
FY 2023-24 Standalone 2024-04-30 6,277.75
FY 2024-25 Standalone 2025-05-31 6,749.21
FY 2025-26 Standalone 2026-02-28 7,431.39

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error